pericapsular nerve group block and lateral femoral cutaneous nerve block for Analgesia

Phase-Based Progress Estimates
1
Effectiveness
1
Safety
SSM Healthcare Bone and Joint Hosptial at St Anthony, Oklahoma City, OK
Analgesia
Pericapsular Nerve Group Block with Lateral Femoral Cutaneous Nerve Block - Procedure
Eligibility
18+
All Sexes
What conditions do you have?
Select

Study Summary

This study compares 2 commonly used interventions (regional pain blocks) used in hip arthroplasty for pain control. One of the interventions is newer and not widely established.

Treatment Effectiveness

Study Objectives

1 Primary · 0 Secondary · Reporting Duration: 1 year

1 year
Verbal Numeric Pain Score Comparison of Pericapsular Nerve Group (PENG) Block and Lateral Femoral Cutaneous Nerve (LFCN) Block to Fascia Iliaca Compartment Block (FICB) in Patients Undergoing Primary Total Hip Arthroplasty (THA).

Trial Safety

Trial Design

2 Treatment Groups

pericapsular nerve group block and lateral femoral cutaneous nerve block
1 of 2
fascia iliaca compartment block
1 of 2
Active Control

105 Total Participants · 2 Treatment Groups

Primary Treatment: pericapsular nerve group block and lateral femoral cutaneous nerve block · No Placebo Group · N/A

pericapsular nerve group block and lateral femoral cutaneous nerve blockActiveComparator Group · 2 Interventions: Pericapsular Nerve Group Block with Lateral Femoral Cutaneous Nerve Block, Fascia Iliaca Compartment Block · Intervention Types: Procedure, Procedure
fascia iliaca compartment blockActiveComparator Group · 2 Interventions: Pericapsular Nerve Group Block with Lateral Femoral Cutaneous Nerve Block, Fascia Iliaca Compartment Block · Intervention Types: Procedure, Procedure

Trial Logistics

Trial Timeline

Approximate Timeline
Screening: ~3 weeks
Treatment: Varies
Reporting: 1 year
Closest Location: SSM Healthcare Bone and Joint Hosptial at St Anthony · Oklahoma City, OK
Photo of oklahoma city 1Photo of oklahoma city 2Photo of oklahoma city 3
N/AFirst Recorded Clinical Trial
1 TrialsResearching Analgesia
0 CompletedClinical Trials

Who is running the clinical trial?

SSM Health Bone and Joint Hospital at St AnthonyLead Sponsor

Eligibility Criteria

Age 18+ · All Participants · 1 Total Inclusion Criteria

Mark “yes” if the following statements are true for you:

About The Reviewer

Michael Gill preview

Michael Gill - B. Sc.

First Published: October 9th, 2021

Last Reviewed: August 12th, 2022

Michael Gill holds a Bachelors of Science in Integrated Science and Mathematics from McMaster University. During his degree he devoted considerable time modeling the pharmacodynamics of promising drug candidates. Since then, he has leveraged this knowledge of the investigational new drug ecosystem to help his father navigate clinical trials for multiple myeloma, an experience which prompted him to co-found Power Life Sciences: a company that helps patients access randomized controlled trials.

References